Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Tubules, Proximal | 4 | 2025 | 34 | 2.490 |
Why?
|
| Diabetic Nephropathies | 5 | 2019 | 74 | 2.400 |
Why?
|
| Kidney Glomerulus | 5 | 2018 | 85 | 1.680 |
Why?
|
| Epithelial Cells | 5 | 2019 | 426 | 1.680 |
Why?
|
| Kidney | 3 | 2025 | 363 | 1.350 |
Why?
|
| Serum Albumin | 2 | 2018 | 58 | 1.110 |
Why?
|
| Endocytosis | 3 | 2018 | 117 | 1.100 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2017 | 95 | 0.960 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2017 | 126 | 0.960 |
Why?
|
| Cell Adhesion Molecules | 2 | 2019 | 84 | 0.940 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2025 | 41 | 0.910 |
Why?
|
| Spheroids, Cellular | 1 | 2025 | 37 | 0.900 |
Why?
|
| Rats, Zucker | 7 | 2019 | 23 | 0.830 |
Why?
|
| Podocytes | 2 | 2015 | 37 | 0.800 |
Why?
|
| Models, Biological | 1 | 2025 | 711 | 0.710 |
Why?
|
| Kidney Tubules | 2 | 2019 | 38 | 0.710 |
Why?
|
| Albuminuria | 2 | 2018 | 78 | 0.700 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2015 | 744 | 0.660 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 47 | 0.610 |
Why?
|
| Palmitic Acid | 1 | 2019 | 23 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2018 | 103 | 0.570 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2018 | 100 | 0.570 |
Why?
|
| Rats | 8 | 2019 | 3701 | 0.540 |
Why?
|
| Apoptosis | 2 | 2025 | 1541 | 0.480 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 25 | 0.480 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 189 | 0.480 |
Why?
|
| Up-Regulation | 2 | 2018 | 534 | 0.470 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 49 | 0.470 |
Why?
|
| Albumins | 1 | 2015 | 32 | 0.460 |
Why?
|
| Cells, Cultured | 5 | 2018 | 1617 | 0.450 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.430 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2014 | 13 | 0.430 |
Why?
|
| Signal Transduction | 3 | 2019 | 2111 | 0.410 |
Why?
|
| Obesity | 2 | 2019 | 1131 | 0.400 |
Why?
|
| Animals | 11 | 2021 | 16695 | 0.390 |
Why?
|
| Palmitates | 2 | 2025 | 15 | 0.390 |
Why?
|
| PPAR alpha | 2 | 2014 | 43 | 0.380 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 181 | 0.370 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 99 | 0.270 |
Why?
|
| Enzyme Activation | 2 | 2018 | 462 | 0.260 |
Why?
|
| Male | 9 | 2021 | 22779 | 0.250 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2025 | 48 | 0.220 |
Why?
|
| Blood Pressure | 1 | 2008 | 662 | 0.220 |
Why?
|
| Autophagy | 1 | 2025 | 136 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1804 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 683 | 0.200 |
Why?
|
| Blotting, Western | 2 | 2015 | 884 | 0.160 |
Why?
|
| Proteinuria | 1 | 2019 | 55 | 0.150 |
Why?
|
| Ischemia | 1 | 2019 | 45 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 46 | 0.150 |
Why?
|
| Osteopontin | 1 | 2019 | 45 | 0.150 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 80 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2019 | 60 | 0.150 |
Why?
|
| Caspase 3 | 1 | 2019 | 226 | 0.150 |
Why?
|
| Cell Line | 2 | 2019 | 1416 | 0.140 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1010 | 0.140 |
Why?
|
| RNA Interference | 1 | 2019 | 246 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 2598 | 0.140 |
Why?
|
| Exosomes | 1 | 2019 | 124 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 436 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1737 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 308 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1554 | 0.120 |
Why?
|
| Cell Compartmentation | 1 | 2015 | 12 | 0.120 |
Why?
|
| Glucose | 1 | 2017 | 242 | 0.120 |
Why?
|
| Clathrin | 1 | 2015 | 21 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 111 | 0.110 |
Why?
|
| Lysosomes | 1 | 2015 | 88 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 196 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 97 | 0.110 |
Why?
|
| Cell Communication | 1 | 2015 | 110 | 0.110 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 4 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2014 | 55 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 49 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 649 | 0.100 |
Why?
|
| Humans | 3 | 2025 | 42163 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.080 |
Why?
|
| Mice | 1 | 2021 | 6490 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2008 | 34 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2008 | 53 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2008 | 44 | 0.070 |
Why?
|
| Collagen Type IV | 1 | 2008 | 48 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 162 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 928 | 0.060 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 52 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 32 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2019 | 107 | 0.040 |
Why?
|
| Cell Movement | 1 | 2019 | 640 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 661 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2019 | 501 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1420 | 0.030 |
Why?
|